Characterization of the Enterobacter Phage vB_EclM_CIP9

Klara Wang; Marielou G Tamayo; Tiffany V Penner; Bradley W M Cook; Deborah A Court; Steven S Theriault

doi:10.1128/MRA.01600-19

Characterization of the Enterobacter Phage vB_EclM_CIP9

Microbiol Resour Announc. 2020 Mar 26;9(13):e01600-19. doi: 10.1128/MRA.01600-19.

Authors

Klara Wang^{1

2}, Marielou G Tamayo¹, Tiffany V Penner², Bradley W M Cook¹, Deborah A Court³, Steven S Theriault^{4

2}

Affiliations

¹ Cytophage Technologies, Inc., Winnipeg, Manitoba, Canada.
² Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
³ Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada deborah.court@umanitoba.ca steven@cytophagetech.com.
⁴ Cytophage Technologies, Inc., Winnipeg, Manitoba, Canada deborah.court@umanitoba.ca steven@cytophagetech.com.

Abstract

Enterobacter cloacae is an opportunistic pathogen that causes hospital-acquired infections in immunocompromised patients. Here, we describe vB_EclM_CIP9, a novel Enterobacter phage that infects a multidrug-resistant isolate of E. cloacae Phage vB_EclM_CIP9 is a myovirus that has a 174,924-bp genome, with 296 predicted open reading frames.